Bank of America’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.79K | Sell |
|
|||||
|
2023
Q4 | $13.7K | Sell |
|
|||||
|
2023
Q3 | $11.3K | Sell |
|
|||||
|
2023
Q2 | $41.3K | Sell |
|
|||||
|
2023
Q1 | $153K | Sell |
|
|||||
|
2022
Q4 | $182K | Sell |
|
|||||
|
2022
Q3 | $534K | Sell |
|
|||||
|
2022
Q2 | $731K | Buy |
|
|||||
|
2022
Q1 | $193K | Sell |
|
|||||
|
2021
Q4 | $473K | Buy |
|
|||||
|
2021
Q3 | $446K | Buy |
|
|||||
|
2021
Q2 | $123K | Sell |
|
|||||
|
2021
Q1 | $847K | Buy |
|